Chloroprocaine for Continuous Epidural Analgesia in Neonates and Infants

NCT02207855 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2016-11-29

No results posted yet for this study

Summary

This a study to retrospectively review our experience with the use of chloroprocaine for postoperative epidural infusions in neonates and infants. Pain scores and the need for intravenous analgesic agents will be recorded from the records to demonstrate the efficacy of the technique.

Conditions

  • Anesthesia

Interventions

DRUG

Chloroprocaine

Sponsors & Collaborators

  • Joseph D. Tobias

    lead OTHER

Principal Investigators

  • Joseph D Tobias, MD · Nationwide Children's Hospital

Eligibility

Max Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02207855 on ClinicalTrials.gov